Read more about the article Responsive Approaches: Adapting Our Work to the New Realities of COVID-19
Work desk with a lighted lamp and computers, working from home

Responsive Approaches: Adapting Our Work to the New Realities of COVID-19

As FHI Clinical begins supporting rapid start-up of clinical trials vital to containing the spread of COVID-19 and protecting the global community, we are also adapting our ongoing work to the new reality of this global pandemic. We are closely monitoring the situation on the ground in the countries where we work and repurposing team members to support COVID-19 response needs.

Continue ReadingResponsive Approaches: Adapting Our Work to the New Realities of COVID-19
Read more about the article Rapid Site Assessment and Recommendations for Clinical Trials of a New Malaria Treatment

Rapid Site Assessment and Recommendations for Clinical Trials of a New Malaria Treatment

Targeted geographic areas for the development of an antimalarial drug by Novartis included malaria-endemic regions in Africa and Asia, and Novartis requested assistance identifying and assessing potential clinical sites for their planned clinical trial. Our team conducted 38 rapid, in-depth, 2.5-day site feasibility assessments in the 18 countries.

Continue ReadingRapid Site Assessment and Recommendations for Clinical Trials of a New Malaria Treatment
Read more about the article We Wrote the Book on How to Approach Outbreaks Like COVID-19. See What We’ve Learned From Our Previous Experience

We Wrote the Book on How to Approach Outbreaks Like COVID-19. See What We’ve Learned From Our Previous Experience

Rules for managing outbreaks were created long before COVID-19. How do we know? Because we’ve been there, we’ve studied outbreaks, and we literally wrote a book on it. Our expert team of infectious disease clinical research specialists have studied outbreaks such as H5N1, HIV, Zika and Ebola. This e-book includes eight key points based on lessons learned from the front lines.

Continue ReadingWe Wrote the Book on How to Approach Outbreaks Like COVID-19. See What We’ve Learned From Our Previous Experience